First U.S. Clinic to Trial INUSpheresis for Detoxification and Longevity

We are the first clinic in the United States selected to receive the INUSpheresis® system later this year as part of a clinical trial toward FDA approval. INUSpheresis is an advanced therapeutic apheresis (blood filtration) system that selectively removes harmful substances from the bloodstream to support deep detoxification, reduce inflammatory proteins, and enhance immune and cellular function. Potential benefits include: - Deep detoxification of heavy metals, pesticides, and environmental toxins - Reduction of inflammatory proteins implicated in autoimmune and chronic inflammatory conditions - Support for cardiovascular health through lowered oxidative stress and improved vascular function - Enhanced immune resilience and reduced pathogenic load - Potential longevity and anti-aging benefits by lowering biological stressors - Improved recovery and performance for athletes and optimization-minded patients Updates will be provided as the trial progresses and clinical data become available.